arginine and Glioblastoma

arginine has been researched along with Glioblastoma in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (13.24)	18.7374
1990's	8 (11.76)	18.2507
2000's	13 (19.12)	29.6817
2010's	29 (42.65)	24.3611
2020's	9 (13.24)	2.80

Authors

Authors	Studies
Fiebig, A; Fiedler, T; Hering, S; Hinz, B; Humboldt, Y; Kämpfer, N; Kreikemeyer, B; Maletzki, C; Schoenwaelder, N; Schwarz, R; Volkmar, K; Zitzow, E	1
Anichini, G; Bomalaski, J; Crook, T; Garcia-Revilla, J; Guo, Y; Hajji, N; Healey, DR; Mateos-Cordero, S; O'Neill, K; Orta-Vázquez, ML; Perryman, R; Quarles, CC; Scheck, AC; Shah, K; Soto, MS; Syed, N; Symington, J; Tzakos, AG; Venero, JL	1
Classen, CF; Del Moral, K; Engel, N; Fiebig, A; Fiedler, T; Frank, M; Freitag, T; Hinz, B; Kaps, P; Koczan, D; Linke, C; Lode, HN; Maletzki, C; Riess, C; Rupprecht, A; Troschke-Meurer, S	1
Alindogan, D; Caldovic, L; Guptan, N; Morizono, M; Owusu-Ansah, M	1
Chen, JP; Cheng, WY; Chiao, MT; Hsieh, WY; Liang, YJ; Lin, CH; Shen, CC; Yang, YC	1
Karatsai, O; Redowicz, MJ; Stasyk, O	1
Chen, JP; Chen, SR; Cheng, WY; Chiao, MT; Dai, XJ; Hsieh, WY; Lee, CH; Liang, YJ; Lin, GS; Liu, BS; Mao, TF; Shen, CC	1
Jensen, ON; Karatsai, O; Rędowicz, MJ; Shliaha, P; Stasyk, O	1
Chang, CW; Lo, YL; Patri, SV; Ravula, V; Wang, LF; Wu, YT	1
Heimberger, AB; Hodges, TR; Shen, J; Song, R; Zhao, H	1
Ishikawa, H; Izumikawa, K; Simpson, RJ; Takahashi, N	1
Das, PP; Hii, L; Law, RHP; Lin, W; Mann, JR; Steer, DL; Udugama, M; Voon, HPJ; Wong, LH	1
Ai, C; Dong, F; Gao, W; Huo, D; Kang, C; Kong, Y; Li, Q; Li, W; Liu, W; Liu, X; Sun, X; Wang, W; Wang, X; Wu, X; Yang, C; Zhou, Y	1
Abaitua, F; Bomalaski, J; Crook, T; Hajitou, A; Hajji, N; Khozoie, C; O'Neill, K; Przystal, JM; Renziehausen, A; Suwan, K; Syed, N; Szlosarek, P; Want, E; Zeng, Q	1
Kim, HA; Lee, M; Oh, B; Yi, N	1
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW	1
Drozak, J; Jagielski, AK; Kunz-Schugart, LA; Olchowik, M; Pavlyk, I; Pereverzieva, G; Redowicz, MJ; Rzhepetskyy, Y; Stasyk, O; Wasik, A	1
Abi-Habib, RJ; El-Sibai, M; Frankel, AE; Ghazale, N; Khoury, O; Stone, E	1
Classen, CF; Fiedler, T; Hering, S; Kreikemeyer, B; Linnebacher, M; Maletzki, C; Redanz, U; Rosche, Y; Strauss, M; William, D	1
Choi, E; Kim, HA; Kim, YH; Lee, HL; Lee, M	1
Chwalibog, A; Grodzik, M; Hotowy, A; Jagiełło, J; Jaworski, S; Kurantowicz, N; Kutwin, M; Lipińska, L; Sawosz, E; Strojny, B; Vadalasetty, KP; Wierzbicki, M	1
Bartoli, L; Beji, S; Falchetti, ML; Farsetti, A; Favia, A; Illi, B; Levi, A; Mongiardi, MP; Nanni, S; Nasi, S; Savino, M; Scagnoli, F	1
Buhrman, JS; Gemeinhart, RA; Liu, Y; Rayahin, JE; Zhang, Y	1
Choy, CT; Loong, HHF; Wong, CH	1
Bae, Y; Choi, JS; Han, J; Ko, KS; Lee, S; Rhim, HS	1
Pollard, PJ; Ratcliffe, PJ	1
Reitman, ZJ; Yan, H	1
Klaassen, M; Kleinschmidt-DeMasters, BK; Nag, K; Sippel, TR; Tsvankin, V; Waziri, A; White, J	1
Knovich, MA; Lesser, GJ; Strowd, RE	1
Awad, M; Bomalaski, J; Coley, HM; Crook, T; Hatzimichael, E; Janczar, K; Langer, J; Lattanzio, L; Lo Nigro, C; O'Neil, K; Roncaroli, F; Singh, P; Syed, N; Szlosarek, P	1
Dörner, E; Gessi, M; Gielen, GH; Hammes, J; Mühlen, AZ; Pietsch, T; Waha, A	1
Closs, EI; Gassner, D; Martiné, U; Niegisch, G; Rotmann, A; Strand, D; Vékony, N	1
Blennow, K; Portelius, E; Thorsell, A; Westman-Brinkmalm, A	1
Baserga, R; Burgaud, JL; Resnicoff, M	1
Alexander, E; Black, PM; Haregewoin, A; Loeffler, JS	1
Closs, EI; Janzen, A; Martiné, U; Strand, D; Vékony, N; Wolf, S	1
He, J; Hou, LJ; Li, WQ; Li, YM; Liu, HM; Lu, YC; Wang, X; Wu, XJ; Xia, CY; Yan, HZ; Yang, DH; Yu, HY	1
Bähr, O; Hattingen, E; Pilatus, U; Ronellenfitsch, MW; Steidl, E; Steinbach, JP; Zanella, F	1
Glas, M; Herrlinger, U; Hundsberger, T; Kurzwelly, D; Nguyen-Huu, B; Rasch, K; Stuplich, M; Wiewrodt, D	1
Chen, J; He, C; He, J; Hu, G; Li, W; Li, Y; Liu, H; Lu, Y; Yang, Y; Yu, H	1
Feng, X; Lin, N; Liu, H; Wang, J; Xu, X; Zhang, B	1
Bertalanffy, H; Bozinov, O; Kalk, JM; Krayenbühl, N; Sure, U; Woernle, CM	1
Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH	1
Guo, D; Hou, L; Mao, P; Mo, L; Xiao, X; Yang, X	1
Li, A; Wang, H; Wang, J; Wang, Q	1
Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M	1
Ernemann, U; Hahn, U; Ritz, R	1
Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D	1
Weller, M	1
Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M	1
Kessinger, A	1
Markwalder, H; Seiler, RW; Zimmermann, A	1
Di Stefano, E; Gerosa, MA; Olivi, A	1
Muse, IM; Wiernik, PH	1
Amistà, P; Berti, F; Brandes, AA; Fiorentino, MV; Gardiman, M; Rigon, A; Rotilio, A; Scelzi, E; Zampieri, P	1
Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O	1
Diete, S; Dietzmann, K; Kirches, E; von Bossanyi, P; Warich-Kirches, M	1
Altavilla, G; Brandes, AA; Carollo, C; Chierichetti, F; Ermani, M; Florentino, MV; Rigon, A; Turazzi, S; Zampieri, P	1
Dichgans, J; Esser, P; Meyermann, R; Rieger, J; Rieger, L; Streffer, J; Weller, M; Winter, S	1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J	1
Buge, A; Huguenin, P; M'orin, P; Mathé, G; Palangie, T; Parrot, R; Poisson, M; Pouillart, P	1
Philippon, J; Poisson, M; Racadot, J; Sichez, JP; van Effenterre, R	1
Foley, JF; Kessinger, A; Lemon, HM	1
Hassoun, J; Paillas, JE; Pellet, W; Peragut, JC; Prince, MA	1
Bleher, EA; Markwalder, H; Seiler, RW; Zimmermann, A	1
Djuric, LJ; Jeremic, B; Jevremovic, S; Jovanovic, D; Mijatovic, LJ	1
Seiler, RW	1

Reviews

6 review(s) available for arginine and Glioblastoma

Article	Year
Effects of Arginine and Its Deprivation on Human Glioblastoma Physiology and Signaling. Advances in experimental medicine and biology, 2020, Volume: 1202 Topics: Animals; Arginine; Endoplasmic Reticulum Stress; Glioblastoma; Humans; Signal Transduction; Unfolded Protein Response	2020
Modulating the expression of Chtop, a versatile regulator of gene-specific transcription and mRNA export. RNA biology, 2018, Volume: 15, Issue:7 Topics: Animals; Arginine; beta-Thalassemia; Glioblastoma; Humans; Introns; Methylation; Mice; Nonsense Mediated mRNA Decay; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA Splicing; RNA, Messenger; Transcription Factors; Transcription, Genetic	2018
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. Journal of the National Cancer Institute, 2010, Jul-07, Volume: 102, Issue:13 Topics: Animals; Arginine; Brain Neoplasms; Codon; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Glucose; Glutarates; Humans; Hypoxia; Isocitrate Dehydrogenase; Mutation; NADP; Neoplasms; Oligodendroglioma; Oncogenes; Signal Transduction; Up-Regulation	2010
[Standards and new developments in the chemotherapy of glioblastomas]. Deutsche medizinische Wochenschrift (1946), 2005, Oct-07, Volume: 130, Issue:40 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Dacarbazine; Decanoic Acids; DNA Modification Methylases; Glioblastoma; Humans; Nimustine; Polyesters; Promoter Regions, Genetic; Temozolomide; Teniposide	2005
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results. Neurosurgery, 1984, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide	1984
Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature. Leukemia, 1996, Volume: 10, Issue:1 Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Glioblastoma; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Male; Neoplasms, Second Primary; Neurofibromatosis 1; Teniposide	1996

Trials

5 trial(s) available for arginine and Glioblastoma

Article	Year
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome	2003
Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas. Surgical neurology, 1980, Volume: 13, Issue:1 Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1980
Early chemotherapy and concurrent radio-chemotherapy in high grade glioma. Journal of neuro-oncology, 1996, Volume: 30, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Survival Analysis; Teniposide; Time Factors	1996
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study. Cancer, 1998, Jan-15, Volume: 82, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Multivariate Analysis; Necrosis; Nitrosourea Compounds; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Analysis; Survival Rate; Teniposide; Thrombocytopenia; Treatment Outcome	1998
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide; Vincristine	1992

Other Studies

57 other study(ies) available for arginine and Glioblastoma

Article	Year
PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes. Applied microbiology and biotechnology, 2022, Volume: 106, Issue:1 Topics: Animals; Arginine; Glioblastoma; Humans; Hydrolases; Mice; Streptococcus pyogenes	2022
Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors. The Journal of clinical investigation, 2022, 03-15, Volume: 132, Issue:6 Topics: Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Glioblastoma; Humans; Hydrolases; Microglia; Polyethylene Glycols	2022
Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells. Cell death & disease, 2022, 06-18, Volume: 13, Issue:6 Topics: Arginine; Autophagy; Cell Line, Tumor; Cyclin-Dependent Kinases; Glioblastoma; Humans	2022
International journal of molecular sciences, 2023, Apr-04, Volume: 24, Issue:7 Topics: Adenocarcinoma of Lung; Amino-Acid N-Acetyltransferase; Arginine; Carbamoyl-Phosphate Synthase (Ammonia); Glioblastoma; Humans; Ligases; Mitochondrial Membrane Transport Proteins; RNA, Messenger; Urea	2023
Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme. BMC cancer, 2023, Sep-20, Volume: 23, Issue:1 Topics: Adult; Arginine; Bevacizumab; Codon; Cyclin-Dependent Kinase Inhibitor p21; Glioblastoma; Humans; Retrospective Studies	2023
Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment. BMC cancer, 2020, Jul-29, Volume: 20, Issue:1 Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Arginine; Bevacizumab; Brain Neoplasms; Codon; Female; Gene Amplification; Genes, p53; Genotype; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Polymorphism, Genetic; Prognosis; Proline; Retrospective Studies; Sequence Analysis, DNA; Taiwan; Treatment Outcome	2020
Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms. Cells, 2020, 09-30, Volume: 9, Issue:10 Topics: Animals; Arginine; Canavanine; Cell Line, Tumor; Glioblastoma; Humans; Protein Biosynthesis; Rats	2020
Arginine-tocopherol bioconjugated lipid vesicles for selective pTRAIL delivery and subsequent apoptosis induction in glioblastoma cells. Materials science & engineering. C, Materials for biological applications, 2021, Volume: 126 Topics: Apoptosis; Arginine; Cell Line, Tumor; Glioblastoma; Humans; Lipids; Liposomes; Plasmids; Tocopherols; Transfection	2021
Identification of metabolites in plasma for predicting survival in glioblastoma. Molecular carcinogenesis, 2018, Volume: 57, Issue:8 Topics: Adult; Arginine; Biomarkers, Tumor; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kynurenic Acid; Male; Metabolome; Metabolomics; Methionine; Middle Aged; Prognosis; Proportional Hazards Models	2018
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma. Nature communications, 2018, 08-07, Volume: 9, Issue:1 Topics: Animals; Arginine; Biotinylation; Brain Neoplasms; Child; Chromatin; Disease Models, Animal; Embryonic Stem Cells; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycine; Histones; Humans; Mice; Mutation; Point Mutation; Protein Binding; Sequence Analysis, RNA; Transgenes	2018
PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma. Nature communications, 2018, 10-31, Volume: 9, Issue:1 Topics: Arginine; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Oncogenes; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Transcription, Genetic	2018
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM. Cell death & disease, 2018, 12-13, Volume: 9, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Hydrolases; Mice; Polyethylene Glycols; Temozolomide; Xenograft Model Antitumor Assays	2018
Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma. Journal of drug targeting, 2014, Volume: 22, Issue:2 Topics: Animals; Antineoplastic Agents; Arginine; Carmustine; Cell Line, Tumor; Drug Delivery Systems; Genetic Therapy; Glioblastoma; Hydrophobic and Hydrophilic Interactions; Micelles; Peptides; Rats; RNA, Small Interfering; Surface-Active Agents; Transfection; Valine; Vascular Endothelial Growth Factor A	2014
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines. International journal of oncology, 2014, Volume: 45, Issue:2 Topics: Arginine; Ascorbic Acid; Brain Neoplasms; Camellia sinensis; Cell Line, Tumor; Copper; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysine; Manganese; Matrix Metalloproteinases; Micronutrients; Plant Extracts; Proline; Selenium; Tissue Inhibitor of Metalloproteinases; Urokinase-Type Plasminogen Activator	2014
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation. Amino acids, 2015, Volume: 47, Issue:1 Topics: Actin Cytoskeleton; Actins; Arginine; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cytoskeleton; Glioblastoma; Humans; Neoplasm Invasiveness	2015
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. Journal of neuro-oncology, 2015, Volume: 122, Issue:1 Topics: Apoptosis; Arginase; Arginine; Argininosuccinate Synthase; Autophagy; Blotting, Western; Cell Cycle; Cell Proliferation; Flow Cytometry; Glioblastoma; Humans; Polyethylene Glycols; Recombinant Proteins; Tumor Cells, Cultured	2015
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer biology & therapy, 2015, Volume: 16, Issue:7 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Chloroquine; DNA Methylation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hydrolases; Hydroxamic Acids; Male; Mice, Inbred Strains; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pyogenes; Treatment Outcome; Tumor Burden; Vorinostat; Xenograft Model Antitumor Assays	2015
Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model. Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:11 Topics: Animals; Arginine; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glioblastoma; Humans; Oxidation-Reduction; Rats; Thymidine Kinase	2015
Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner. International journal of molecular sciences, 2015, Oct-23, Volume: 16, Issue:10 Topics: Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Glioblastoma; Graphite; NAD(P)H Dehydrogenase (Quinone); Neurons; Oxides; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53	2015
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells. Scientific reports, 2015, Nov-13, Volume: 5 Topics: Adaptor Proteins, Signal Transducing; Arginine; Blotting, Western; Cell Line, Tumor; Chromatin; Glioblastoma; HEK293 Cells; Histones; Humans; Methylation; Microscopy, Confocal; Peptide Fragments; Protein Binding; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-myc; RNA Interference	2015
Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid. Molecular pharmaceutics, 2016, 06-06, Volume: 13, Issue:6 Topics: Antineoplastic Agents; Arginine; Brain Neoplasms; Cerebrospinal Fluid; Drug Delivery Systems; Glioblastoma; Humans; Micelles; MicroRNAs; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers	2016
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg). Journal of neuro-oncology, 2016, Volume: 129, Issue:3 Topics: Adolescent; Adult; Aged; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Glioblastoma; Humans; Middle Aged; Ornithine Carbamoyltransferase; Polyethylene Glycols; Prognosis; Recombinant Proteins; Survival Rate; Young Adult	2016
Apoptin Gene Delivery by the Functionalized Polyamidoamine Dendrimer Derivatives Induces Cell Death of U87-MG Glioblastoma Cells. Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:6 Topics: Apoptosis; Arginine; Brain Neoplasms; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; Dendrimers; DNA; Genetic Therapy; Glioblastoma; Histidine; Humans; Lysine; Transfection	2017
Cancer. Puzzling patterns of predisposition. Science (New York, N.Y.), 2009, Apr-10, Volume: 324, Issue:5924 Topics: Amino Acid Substitution; Arginine; Brain Neoplasms; Citric Acid Cycle; Dinucleoside Phosphates; Fumarate Hydratase; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Glioblastoma; Glutamates; Humans; Hydroxylation; Hypoxia-Inducible Factor 1; Isocitrate Dehydrogenase; Mutation; NADP; Oncogenes; Succinate Dehydrogenase	2009
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Nov-15, Volume: 17, Issue:22 Topics: Arginase; Arginine; Brain Neoplasms; Cell Degranulation; Cells, Cultured; Glioblastoma; Humans; Immune Tolerance; Immunity, Cellular; Molecular Targeted Therapy; Neutrophils; T-Lymphocytes	2011
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Current treatment options in oncology, 2012, Volume: 13, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell death & disease, 2013, Jan-17, Volume: 4 Topics: Apoptosis; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Autophagy; Azacitidine; Central Nervous System Neoplasms; Chloroquine; CpG Islands; Decitabine; DNA Methylation; Epigenomics; Glioblastoma; Humans; Hydrolases; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Stilbenes; Tumor Cells, Cultured; Up-Regulation	2013
H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications? Journal of neuro-oncology, 2013, Volume: 112, Issue:1 Topics: Adolescent; Arginine; Central Nervous System Neoplasms; Child; Child, Preschool; DNA Mutational Analysis; Female; Glioblastoma; Glycine; Histones; Humans; Male; Mutation; Neuroectodermal Tumors, Primitive; Receptor, Platelet-Derived Growth Factor alpha	2013
Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane. The Biochemical journal, 2006, Apr-01, Volume: 395, Issue:1 Topics: Animals; Antibody Specificity; Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Cell Line, Tumor; Cell Membrane; Down-Regulation; Enzyme Activation; Glioblastoma; Humans; Oocytes; Protein Kinase C; Teratocarcinoma; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Xenopus	2006
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment. Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:5 Topics: Arginine; Cell Line, Tumor; Chemical Fractionation; Chromatography, High Pressure Liquid; Glioblastoma; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Isoelectric Focusing; Isotope Labeling; Lamins; Microchemistry; Microfilament Proteins; Molecular Chaperones; Neoplasm Proteins; Peptide Mapping; Peptides; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2007
Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochemical and biophysical research communications, 1995, Sep-14, Volume: 214, Issue:2 Topics: Analysis of Variance; Animals; Apoptosis; Arginine; Binding Sites; Brain Neoplasms; Cell Division; Cell Line; Glioblastoma; Humans; Lysine; Mutagenesis, Site-Directed; Point Mutation; Rats; Receptor, IGF Type 1; Recombinant Proteins; Transfection; Tumor Cells, Cultured	1995
Autocrine regulation of the production of the gaseous messenger nitric oxide in a glioblastoma cell line. Experimental cell research, 1994, Volume: 210, Issue:1 Topics: Arginine; Cytokines; Dexamethasone; Glioblastoma; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Time Factors; Tumor Cells, Cultured	1994
Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity. The Biochemical journal, 2002, Jun-15, Volume: 364, Issue:Pt 3 Topics: Amino Acid Sequence; Amino Acid Transport System y+; Amino Acids; Animals; Arginine; Cell Membrane; DNA Primers; Glioblastoma; Green Fluorescent Proteins; Humans; Kinetics; Luminescent Proteins; Mammals; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Fusion Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Teratocarcinoma; Tumor Cells, Cultured; Xenopus laevis	2002
Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor. Biochemical and biophysical research communications, 2014, Apr-18, Volume: 446, Issue:4 Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Mice, Nude; MicroRNAs; Prognosis; RNA-Binding Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Up-Regulation	2014
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine	2015
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. PloS one, 2016, Volume: 11, Issue:12 Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Female; Glioblastoma; Humans; Hydrogen; Inositol; Lomustine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Tumor Microenvironment; Vascular Endothelial Growth Factor A	2016
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma. Oncology, 2009, Volume: 76, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Retrospective Studies; Teniposide	2009
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain research, 2009, Aug-25, Volume: 1286 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Teniposide; Transfection	2009
Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1 Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Carmustine; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Fibroblast Growth Factor 2; Glioblastoma; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Teniposide; Tumor Cells, Cultured	2011
Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas. Neurologia medico-chirurgica, 2010, Volume: 50, Issue:8 Topics: Actins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Exotoxins; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunotoxins; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Recombinant Fusion Proteins; RNA; Teniposide; Young Adult	2010
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:3 Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult	2011
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2 Topics: Acetone; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Fluorescent Dyes; Glioblastoma; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Teniposide; Thiazoles	2012
Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26. International journal of clinical and experimental pathology, 2012, Volume: 5, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Brain; Brain Neoplasms; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Knockdown Techniques; Gene Silencing; Glioblastoma; Humans; Muscle Proteins; Teniposide	2012
[Glioblastoma multiforme of the optic nerve]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11 Topics: Antineoplastic Agents; Contrast Media; Diagnosis, Differential; Follow-Up Studies; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nimustine; Optic Nerve; Optic Nerve Neoplasms; Teniposide; Time Factors	2004
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC cancer, 2005, May-30, Volume: 5 Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome	2005
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). BMC cancer, 2006, Oct-18, Volume: 6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome	2006
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report. Surgical neurology, 1981, Volume: 15, Issue:2 Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide	1981
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue. Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide	1997
Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy. Acta neuropathologica, 1997, Volume: 94, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Karnofsky Performance Status; Nimustine; Teniposide	1997
Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo. Acta neuropathologica, 2000, Volume: 99, Issue:5 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Carmustine; Combined Modality Therapy; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; In Vitro Techniques; Male; Middle Aged; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Topotecan; Tumor Cells, Cultured; Verapamil; Vincristine	2000
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. Journal of neuro-oncology, 2000, Volume: 48, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53	2000
[Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU]. Bulletin du cancer, 1977, Volume: 64, Issue:1 Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Glioblastoma; Humans; Lomustine; Methods; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1977
Cerebral pseudocysts following chemotherapy of glioblastomas. Acta neurochirurgica, 1977, Volume: 39, Issue:3-4 Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Cysts; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide; Tomography, X-Ray Computed	1977
Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain. Journal of surgical oncology, 1978, Volume: 10, Issue:6 Topics: Brain Neoplasms; Carmustine; Drug Administration Schedule; Glioblastoma; Humans; Teniposide; Vomiting	1978
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months]. Revue neurologique, 1979, Volume: 135, Issue:3 Topics: Administration, Oral; Adult; Brain Neoplasms; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Retrospective Studies; Teniposide	1979
Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas. Surgical neurology, 1979, Volume: 12, Issue:2 Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide	1979
[Multimodal treatment of undifferentiated astrocytomas of the cerebrum. Indications for chemotherapy]. Fortschritte der Medizin, 1985, Jun-06, Volume: 103, Issue:21 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Glioblastoma; Humans; Lomustine; Teniposide	1985